home-banner

Immunotherapy

As immunotherapy for cancer continues to evolve—so has the Association of Community Cancer Centers—adapting to meet the changing needs of the oncology community.

The ACCC Immuno-Oncology Institute is the only initiative dedicated to educating multidisciplinary teams to go beyond a clinical understanding of IO and tackle real-world implementation issues. With the care of patients on immunotherapies now extending beyond the cancer team, the ACCC Immuno-Oncology Institute is at the forefront of developing critical education to empower healthcare professionals across care delivery settings.

Under the guidance of the IO Institute Executive Committee, multispecialty Working Groups were established to focus on Big Data, Telemedicine, Care Coordination and Communication, and Training and Education. IO Working Groups members share their expertise, knowledge, and forward-looking perspectives to provide a framework for developing proactive strategies for effective delivery of these new and emerging therapies.

For more information on this project, please contact the ACCC Provider Education department.

Featured Publication

Immuno-Oncology in 2021: Committed to the Cutting Edge of CareDownload

Cancer Buzz Podcasts

  • Navigating the Operational Challenges of Treatment with Bispecific Antibodies - [Podcast] Ep 148
    Mar 28, 2024

    Advancements in clinical data and research have shown the immunotherapeutic potential of bispecific antibodies as treatment for hematologic cancers and solid tumors. In this episode, CANCER BUZZ speaks with Aaron Cumpston, PharmD, pharmacy clinical specialist in hematologic malignancies and bone marrow transplant and Christine Barrett, PharmD, BCOP, medical oncology clinical pharmacy specialist at WVU Cancer Institute who discuss the challenges of care coordination and therapy and share operational best practices for the delivery of bispecific antibodies in the community setting.

  • Is It Time to Cancel the Term “A Cure for Cancer” – [VIDEO PODCAST] Ep 20
    Oct 27, 2022

    Dr. Sanjay Juneja explores how—with many cancers now being treated like a chronic disease—it may be time to cancel the term “a cure for cancer.” 

  • [PODCAST] Ep 75: Developments in TIL Cell Therapy
    Jan 25, 2022

    In this episode, hear from two experts in cancer immunotherapy on the exciting potential of TIL Cell Therapy in melanoma and beyond.

  • [PODCAST] Ep 35: Immunotherapy & Dermatology
    Aug 25, 2020

    Learn about dermatology’s role in the cancer care continuum and how cancer teams can better integrate dermatology into the immunotherapy care process.

  • [PODCAST] Ep 26: IO Clinical Trials During COVID-19
    Jun 23, 2020

    We explore how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials.

  • [PODCAST] Ep 22: Immunotherapy & Mental Health
    May 27, 2020

    Learn about the mental health implications of treatment with cancer immunotherapy, and how cancer care providers can better integrate mental health awareness into the IO care continuum.

  • [PODCAST] Ep 10: The Immunotherapy Patient Perspective
    Jan 15, 2020

    We sat down with journalist Mary Elizabeth Williams, one of the first patients treated with combination immunotherapy, to discuss her experience as an IO patient and how to bridge communication gaps among patients, doctors, and researchers.

  • [PODCAST] Ep 08: Immunotherapy and Emergency Medicine
    Nov 27, 2019

    Learn why a trip to the emergency department is different for patients who receive immunotherapy for cancer, what information helps ED clinicians, and what busy emergency department providers need to know about immune-related adverse events.

  • [PODCAST] Ep 04: Survivorship Care After Immunotherapy
    Sep 11, 2019

    Learn about the transition from immunotherapy into post-treatment survivorship, how it differs from chemotherapy, and why coordination and communication among providers, patients, and caregivers is essential.

Telemedicine & Virtual Navigation

From the ACCCBuzz Blog